Teli Liu
Overview
Explore the profile of Teli Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
360
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guo X, Liu J, Lin S, Gui X, Ding J, Liu T, et al.
Clin Nucl Med
. 2025 Jan;
PMID: 39854676
Purpose: The aim of this study was to compare Al18F-NOTA-HER2-BCH and 18F-FDG for detecting nodal metastases in patients with HER2-positive breast cancer on PET/CT. Patients And Methods: In this retrospective...
2.
Ma X, Liu T, Guo R, Zhou W, Yao Y, Wen D, et al.
Eur J Nucl Med Mol Imaging
. 2024 Nov;
52(4):1406-1421.
PMID: 39549046
Background: To develop the extracellular matrix metalloproteinase inducer (CD147)-targeting therapeutic strategies, accurate detection of CD147 expression in tumors is crucial. Owing to their relatively low molecular weights and high affinities,...
3.
Yao Y, Ren Y, Hou X, Wang P, Zhu J, Liu S, et al.
Eur J Nucl Med Mol Imaging
. 2024 Aug;
52(1):36-47.
PMID: 39155310
Purpose: NB12 is a bispecific antibody that consists of two anti-programmed cell death-ligand 1 (PD-L1) nanobodies and two anti-programmed cell death-ligand 2 (PD-L2) nanobodies. The aim of this study was...
4.
Ding L, Wang F, Wang Z, Pan Y, Liu T, Cheng L, et al.
Mol Pharm
. 2024 Jun;
21(8):3992-4003.
PMID: 38941565
Lymphocyte activation gene 3 (LAG-3) has attracted much attention as a potentially valuable immune checkpoint. Individual identification of LAG-3 expression at screening and during treatment could improve the successful implementation...
5.
Ding J, Zhang Q, Jiang J, Zhou N, Yu Z, Wang Z, et al.
ACS Pharmacol Transl Sci
. 2024 Jun;
7(6):1758-1769.
PMID: 38898955
Angiotensin-converting enzyme 2 (ACE2) is the main molecular target for coronavirus SARS-CoV-2 to enter cells. Molecularly specific tracers that bind to ACE2 with high affinity can be used to determine...
6.
Guo X, Zhou N, Liu J, Ding J, Liu T, Song G, et al.
Radiology
. 2024 Jun;
311(3):e232209.
PMID: 38888484
Background Human epidermal growth factor receptor 2 (HER2) affibody-based tracers could be an alternative to nonspecific radiotracers for noninvasive detection of HER2 expression in breast cancer lesions at PET/CT. Purpose...
7.
He C, Guo Y, Zhou N, Wang Z, Liu T, Xu X, et al.
Int J Nanomedicine
. 2024 Jun;
19:5479-5492.
PMID: 38863646
Background: In recent years, PD-L1 has been primarily utilized as an immune checkpoint marker in cancer immunotherapy. However, due to tumor heterogeneity, the response rate to such therapies often falls...
8.
Ren Y, Liu T, Li S, Ma X, Xia L, Wang P, et al.
Int J Pharm
. 2023 Dec;
651:123756.
PMID: 38160990
Background And Purpose: Some kinds of antibody-drug conjugate (ADC) with high affinity to Nectin-4 have demonstrated breakthrough progress in the third-line setting for bladder cancer. However, many patients are still...
9.
Yao Y, Ren Y, Hou X, Zhu J, Ma X, Liu S, et al.
Biomed Pharmacother
. 2023 Oct;
168:115602.
PMID: 37852097
Objectives: The aim of this study was to design a novel tracer targeting programmed cell death-ligand 2 (PD-L2) to dynamically monitor PD-L2 expression and perform preclinical screening to identify patients...
10.
Preparation and Application of a Bioorganic Nanoparticle-Enhanced PDL1-Targeted Small-Molecule Probe
Xia L, He C, Guo Y, Meng X, Liu T, Xu X, et al.
ACS Appl Mater Interfaces
. 2023 Jun;
15(25):30619-30629.
PMID: 37310115
Programmed death ligand 1 (PDL1) is a specific molecular target for the diagnosis and immunotherapy of solid tumors. PET imaging can be used for noninvasive assessments of PDL1 expression in...